Aditx Therapeutics
Thomas Eaton has a strong background in finance, with experience in senior roles at various companies. Thomas started their career at Brown Brothers Harriman in 2015, where they focused on alternative investments in the investor services division. In 2018, Thomas joined Benefit Street Partners as a Senior Associate, where they worked until 2020. Thomas then moved on to Aditxt, first as the Director of Finance in 2021, and later promoted to the role of Vice President - Finance in 2022.
Thomas Eaton attended the University of Delaware, where they obtained a Bachelor of Science degree in Finance from the Alfred Lerner School of Business and Economics. Thomas also completed the Core and Equity Essentials Certifications from Bloomberg LP in 2014.
This person is not in any offices
Aditx Therapeutics
Aditx Therapeutics, Inc. (Aditxt™) is a biotech innovation company with a mission of prolonging life and enhancing its quality by improving the health of the immune system.